This page shows Spartannash Co (SPTN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
SpartanNash’s economics are driven by a thin-profit distribution model where small shifts in overhead, interest, and capex reshape results.
From FY2023 to FY2024, operating cash flow rose to$205.9M even as net income fell to$299K ; that gap says the near-break-even earnings line did not reflect the year’s cash production. But with$132.4M of capex and only$21.6M of cash on hand, much of that cash was needed to keep the asset base moving rather than building a cash cushion.
Gross margin improved in FY2024 to
The balance sheet is liquid enough for day-to-day operations with a current ratio of 1.6x, but cash was only
Financial Health Signals
Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Spartannash Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Spartannash Co has an operating margin of 0.6%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 48/100, indicating healthy but not exceptional operating efficiency. This is down from 1.1% the prior year.
Spartannash Co's revenue declined 1.8% year-over-year, from $9.7B to $9.5B. This contraction results in a growth score of 30/100.
Spartannash Co has elevated debt relative to equity (D/E of 2.50), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 25/100, reflecting increased financial risk.
Spartannash Co's current ratio of 1.57 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.
Spartannash Co's free cash flow margin of 0.8% results in a low score of 29/100. Capital expenditures of $132.4M absorb a large share of operating cash flow.
Spartannash Co's ROE of 0.0% shows moderate profitability relative to equity, earning a score of 54/100. This is down from 6.7% the prior year.
Spartannash Co scores 4.37, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Spartannash Co passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Spartannash Co generates $688.55 in operating cash flow ($205.9M OCF vs $299K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Spartannash Co earns $1.2 in operating income for every $1 of interest expense ($54.0M vs $44.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Spartannash Co generated $9.5B in revenue in fiscal year 2024. This represents a decrease of 1.8% from the prior year.
Spartannash Co's EBITDA was $157.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 23.4% from the prior year.
Spartannash Co reported $299K in net income in fiscal year 2024. This represents a decrease of 99.4% from the prior year.
Spartannash Co earned $0.01 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 99.3% from the prior year.
Cash & Balance Sheet
Spartannash Co generated $73.5M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 337.0% from the prior year.
Spartannash Co held $21.6M in cash against $0 in long-term debt as of fiscal year 2024.
Spartannash Co paid $0.87 per share in dividends in fiscal year 2024. This represents an increase of 1.2% from the prior year.
Spartannash Co had 34M shares outstanding in fiscal year 2024. This represents a decrease of 2.5% from the prior year.
Margins & Returns
Spartannash Co's gross margin was 15.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the prior year.
Spartannash Co's operating margin was 0.6% in fiscal year 2024, reflecting core business profitability. This is down 0.5 percentage points from the prior year.
Spartannash Co's net profit margin was 0.0% in fiscal year 2024, showing the share of revenue converted to profit. This is down 0.5 percentage points from the prior year.
Spartannash Co's ROE was 0.0% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 6.7 percentage points from the prior year.
Capital Allocation
Spartannash Co spent $15.0M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 19.0% from the prior year.
Spartannash Co invested $132.4M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 10.0% from the prior year.
SPTN Income Statement
| Metric | Q3'25 | Q2'25 | Q4'24 | Q3'24 | Q2'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B-21.9% | $2.9B+29.3% | $2.3B+0.9% | $2.2B-20.5% | $2.8B+23.9% | $2.3B-2.1% | $2.3B-20.5% | $2.9B |
| Cost of Revenue | $1.9B-22.2% | $2.4B+28.1% | $1.9B+1.0% | $1.9B-20.6% | $2.4B+23.4% | $1.9B-2.2% | $2.0B-20.3% | $2.5B |
| Gross Profit | $382.6M-20.5% | $481.5M+35.8% | $354.6M+0.5% | $353.0M-19.8% | $440.3M+26.7% | $347.5M-1.4% | $352.4M-21.1% | $446.7M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $355.3M-22.6% | $459.1M+41.7% | $324.1M+1.9% | $318.2M-21.2% | $403.6M+25.0% | $322.8M+1.3% | $318.8M-23.8% | $418.2M |
| Operating Income | $18.1M-4.4% | $19.0M-23.9% | $24.9M-4.6% | $26.1M-14.7% | $30.6M+32.7% | $23.1M-35.5% | $35.8M+47.2% | $24.3M |
| Interest Expense | $12.3M-19.3% | $15.2M+53.4% | $9.9M-5.9% | $10.5M-21.8% | $13.5M+45.3% | $9.3M-0.7% | $9.3M-19.3% | $11.6M |
| Income Tax | -$138K-107.2% | $1.9M-55.3% | $4.3M-7.4% | $4.6M-10.8% | $5.2M+50.9% | $3.5M-54.9% | $7.7M+215.5% | $2.4M |
| Net Income | $6.2M+197.6% | $2.1M-81.0% | $10.9M-5.0% | $11.5M-11.4% | $13.0M+16.6% | $11.1M-42.8% | $19.5M+71.7% | $11.3M |
| EPS (Diluted) | $0.18+200.0% | $0.06-81.3% | $0.32-5.9% | $0.34-8.1% | $0.37+15.6% | $0.32-42.9% | $0.56+75.0% | $0.32 |
SPTN Balance Sheet
| Metric | Q3'25 | Q2'25 | Q4'24 | Q3'24 | Q2'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B-0.9% | $2.6B+4.6% | $2.5B+4.3% | $2.4B+1.0% | $2.3B+0.3% | $2.3B+0.3% | $2.3B+1.3% | $2.3B |
| Current Assets | $1.1B-1.0% | $1.1B-3.6% | $1.1B+9.1% | $1.0B-2.0% | $1.1B-2.0% | $1.1B+0.2% | $1.1B+1.5% | $1.1B |
| Cash & Equivalents | $25.5M+27.7% | $20.0M+14.0% | $17.5M-30.6% | $25.2M+33.1% | $19.0M+8.1% | $17.6M+3.8% | $16.9M-0.3% | $17.0M |
| Inventory | $530.1M+0.5% | $527.4M-5.5% | $558.0M+5.8% | $527.6M-5.0% | $555.4M-4.2% | $579.6M+0.5% | $576.9M+1.9% | $566.3M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $181.0M0.0% | $181.0M-4.7% | $190.0M-0.1% | $190.2M+4.4% | $182.2M0.0% | $182.2M0.0% | $182.2M0.0% | $182.2M |
| Total Liabilities | $1.8B-1.4% | $1.8B+9.2% | $1.7B+6.1% | $1.6B+2.1% | $1.6B0.0% | $1.6B-0.1% | $1.6B+1.4% | $1.5B |
| Current Liabilities | $693.5M+4.7% | $662.6M-5.6% | $701.6M+9.1% | $643.3M+5.8% | $608.0M-10.9% | $682.4M+1.8% | $670.5M+5.7% | $634.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $741.8M+0.3% | $739.5M-5.3% | $781.3M+0.6% | $776.3M-1.1% | $785.2M+1.0% | $777.3M+1.2% | $768.4M+1.2% | $759.5M |
| Retained Earnings | $280.1M-0.5% | $281.6M-14.6% | $329.6M+1.0% | $326.3M+1.2% | $322.4M+2.6% | $314.3M+1.2% | $310.6M+4.0% | $298.7M |
SPTN Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q4'24 | Q3'24 | Q2'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $86.7M+235.8% | $25.8M+392.1% | -$8.8M-109.2% | $95.6M+162.3% | $36.5M-20.8% | $46.0M-12.1% | $52.4M+2033.7% | -$2.7M |
| Capital Expenditures | $19.6M-38.0% | $31.6M+2.6% | $30.8M+14.4% | $26.9M-33.0% | $40.2M+58.2% | $25.4M+15.6% | $22.0M-43.5% | $38.9M |
| Free Cash Flow | $67.1M+1264.8% | -$5.8M+85.5% | -$39.6M-157.7% | $68.7M+1957.4% | -$3.7M-117.9% | $20.6M-32.1% | $30.4M+173.1% | -$41.6M |
| Investing Cash Flow | -$22.5M+39.2% | -$37.0M-18.6% | -$31.2M+24.7% | -$41.4M-8.6% | -$38.1M-52.7% | -$24.9M-40.3% | -$17.8M+54.7% | -$39.3M |
| Financing Cash Flow | -$58.7M-716.0% | $9.5M-70.5% | $32.3M+167.3% | -$48.0M-1913.6% | $2.6M+112.9% | -$20.4M+41.0% | -$34.6M-216.0% | $29.9M |
| Dividends Paid | $7.7M-4.4% | $8.0M+6.2% | $7.6M-0.1% | $7.6M-6.3% | $8.1M+8.2% | $7.5M-0.7% | $7.5M-3.8% | $7.8M |
| Share Buybacks | $0 | $0 | $0-100.0% | $12.4M+375.3% | $2.6M | $0-100.0% | $7.6M-30.2% | $10.9M |
SPTN Financial Ratios
| Metric | Q3'25 | Q2'25 | Q4'24 | Q3'24 | Q2'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 16.9%+0.3pp | 16.6%+0.8pp | 15.8%-0.1pp | 15.8%+0.1pp | 15.7%+0.3pp | 15.3%+0.1pp | 15.2%-0.1pp | 15.4% |
| Operating Margin | 0.8%+0.2pp | 0.7%-0.5pp | 1.1%-0.1pp | 1.2%+0.1pp | 1.1%+0.1pp | 1.0%-0.5pp | 1.6%+0.7pp | 0.8% |
| Net Margin | 0.3%+0.2pp | 0.1%-0.4pp | 0.5%-0.0pp | 0.5%+0.1pp | 0.5%-0.0pp | 0.5%-0.3pp | 0.8%+0.4pp | 0.4% |
| Return on Equity | 0.8%+0.5pp | 0.3%-1.1pp | 1.4%-0.1pp | 1.5%-0.2pp | 1.7%+0.2pp | 1.4%-1.1pp | 2.5%+1.0pp | 1.5% |
| Return on Assets | 0.2%+0.2pp | 0.1%-0.4pp | 0.4%-0.0pp | 0.5%-0.1pp | 0.5%+0.1pp | 0.5%-0.4pp | 0.8%+0.3pp | 0.5% |
| Current Ratio | 1.57-0.1 | 1.66+0.0 | 1.620.0 | 1.62-0.1 | 1.75+0.2 | 1.59-0.0 | 1.62-0.1 | 1.69 |
| Debt-to-Equity | 2.45-0.0 | 2.49+0.3 | 2.16+0.1 | 2.05+0.1 | 1.98-0.0 | 2.00-0.0 | 2.030.0 | 2.02 |
| FCF Margin | 3.0%+3.2pp | -0.2%+1.6pp | -1.8%-4.8pp | 3.1%+3.2pp | -0.1%-1.0pp | 0.9%-0.4pp | 1.3%+2.7pp | -1.4% |
Similar Companies
Frequently Asked Questions
What is Spartannash Co's annual revenue?
Spartannash Co (SPTN) reported $9.5B in total revenue for fiscal year 2024. This represents a -1.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Spartannash Co's revenue growing?
Spartannash Co (SPTN) revenue declined by 1.8% year-over-year, from $9.7B to $9.5B in fiscal year 2024.
Is Spartannash Co profitable?
Yes, Spartannash Co (SPTN) reported a net income of $299K in fiscal year 2024, with a net profit margin of 0.0%.
What is Spartannash Co's EBITDA?
Spartannash Co (SPTN) had EBITDA of $157.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Spartannash Co's gross margin?
Spartannash Co (SPTN) had a gross margin of 15.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Spartannash Co's operating margin?
Spartannash Co (SPTN) had an operating margin of 0.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Spartannash Co's net profit margin?
Spartannash Co (SPTN) had a net profit margin of 0.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Spartannash Co pay dividends?
Yes, Spartannash Co (SPTN) paid $0.87 per share in dividends during fiscal year 2024.
What is Spartannash Co's return on equity (ROE)?
Spartannash Co (SPTN) has a return on equity of 0.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Spartannash Co's free cash flow?
Spartannash Co (SPTN) generated $73.5M in free cash flow during fiscal year 2024. This represents a 337.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Spartannash Co's operating cash flow?
Spartannash Co (SPTN) generated $205.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Spartannash Co's total assets?
Spartannash Co (SPTN) had $2.6B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Spartannash Co's capital expenditures?
Spartannash Co (SPTN) invested $132.4M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is Spartannash Co's current ratio?
Spartannash Co (SPTN) had a current ratio of 1.57 as of fiscal year 2024, which is generally considered healthy.
What is Spartannash Co's debt-to-equity ratio?
Spartannash Co (SPTN) had a debt-to-equity ratio of 2.50 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Spartannash Co's return on assets (ROA)?
Spartannash Co (SPTN) had a return on assets of 0.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Spartannash Co's Altman Z-Score?
Spartannash Co (SPTN) has an Altman Z-Score of 4.37, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Spartannash Co's Piotroski F-Score?
Spartannash Co (SPTN) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Spartannash Co's earnings high quality?
Spartannash Co (SPTN) has an earnings quality ratio of 688.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Spartannash Co cover its interest payments?
Spartannash Co (SPTN) has an interest coverage ratio of 1.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Spartannash Co?
Spartannash Co (SPTN) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.